Stereotaxis' MAGiC catheter received CE Mark approval in Europe, enabling the company to earn an additional $3k per procedure with +80% gross margins. FDA approval of MAGiC is expected by September.

Celanese (NYSE:CE) is facing significant challenges as customer demand deteriorates, negatively impacting both sales volumes and prices. The company anticipates these difficult conditions will persist ...

On May 20, BMO Capital Markets changed its stance on Celanese Corporation (NYSE:CE)’s stock, upgrading it from an "Underperform" to a "Market Perform" rating and lifting the price target to $55 from ...

Celanese Corporation, a global chemicals company, derives 54% of its revenue from engineered materials and 46% from the acetyl chain, with high-margin operations. Celanese's Engineered Materials ...

We recently published a list of 14 Most Expensive Stocks Insiders Are Buying In March. In this article, we are going to take a look at where Celanese Corporation (NYSE:CE) stands against other most ...

Celanese Corp (NYSE:CE) stock is up 5.4% to trade at $44.65 at last glance, after the chemicals company was upgraded by Citigroup to "buy" from "neutral," to go with a price-target hike to $53 from ...

$CE insiders have traded $CE stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales. Here’s a breakdown ...